A phase I–II study of gemcitabine and docetaxel in advanced pancreatic cancer: A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)
Stefano Cascinu(Vita-Salute San Raffaele University), Giuseppina Catalano(Unknown), Alessandro Morabito(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), R R Silva, Domenico Gattuso, Paolo Giordani(University of Genoa), Giulio Gasparini, G. Pancera, Vincenzo Catalano(Azienda Ospedaliero-Universitaria delle Marche)
Cited by 50
Related Papers
Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial
|The Lancet Oncology|2019|1.7k
Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2022|1.4k
Neuroprotective Effect of Reduced Glutathione on Oxaliplatin-Based Chemotherapy in Advanced Colorectal Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial
|Journal of Clinical Oncology|2002|416
Recombinant human erythropoietin treatment in cisplatin-associated anemia: a randomized, double-blind trial with placebo.
|Journal of Clinical Oncology|1994|200
Randomized Trial of Low-Dose Morphine Versus Weak Opioids in Moderate Cancer Pain
|Journal of Clinical Oncology|2015|181